Assembly Biosciences
(NASDAQ) ASMB
Assembly Biosciences Financials at a Glance
Market Cap
$446.48M
Revenue (TTM)
$71.10M
Net Income (TTM)
-$6.38M
EPS (TTM)
-$1.20
P/E Ratio
-18.76
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$23.14
Volume
5,410
Open
$22.45
Price
$23.14
Volume
5,410
Open
$22.45
Previous Close
$23.14
Daily Range
$22.45 - $23.68
52-Week Range
$15.84 - $39.71
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$23.14
Volume
5,410
Open
$22.45
Previous Close
$23.14
Daily Range
$22.45 - $23.68
52-Week Range
$15.84 - $39.71
Estimated Earnings Date
Aug 5, 2026
ASMB News
ASMB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Assembly Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
73
CEO
Jason A. Okazaki
Website
www.assemblybio.comHeadquarters
South San Francisco, CA 94080, US
ASMB Financials
Key Financial Metrics (TTM)
Gross Margin
77%
Operating Margin
-19%
Net Income Margin
-9%
Return on Equity
-6%
Return on Capital
-7%
Return on Assets
-3%
Earnings Yield
-5.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$446.48M
Shares Outstanding
19.82M
Volume
5.41K
Avg. Volume
138.00K
Financials (TTM)
Gross Profit
$72.17M
Operating Income
-$12.12M
EBITDA
-$5.99M
Operating Cash Flow
-$41.09M
Capital Expenditure
-$66.00K
Free Cash Flow
-$41.16M
Cash & ST Invst.
$248.11M
Total Debt
$2.63M
Assembly Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.21M
-12.8%
Gross Profit
$8.19M
-13.1%
Gross Margin
99.68%
N/A
Market Cap
$446.48M
N/A
Market Cap/Employee
$6.12M
N/A
Employees
73
N/A
Net Income
-$9.08M
-3.0%
EBITDA
-$9.05M
-3.1%
Quarterly Fundamentals
Total Cash
$226.60M
+148.9%
Total Debt
$2.49M
-17.5%
Accounts Receivable
$451.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.90M
-23.7%
Short Term Debt
$590.00K
+11.5%
Return on Assets
-2.71%
N/A
Return on Invested Capital
-6.76%
N/A
Free Cash Flow
-$22.12M
+5.6%
Operating Cash Flow
-$22.10M
+5.7%